Under construction – not a live service
Sign in
Taking people in ChinaNo phase

The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders

Key facts

Where
Suzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 75 years old?

Source: NCT06797284, who can take part

Where in China

  • Department of Neurology, Second Affiliated Hospital of Soochow UniversitySuzhou, ChinaContact: Chun-Feng Liu, Ph.D, M.D.Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Second Affiliated Hospital of Soochow University
Trial code
NCT06797284
Record updated
14 February 2025
Original description
Carry out precise and effective neuromodulation interventions, and develop new neuromodulation technologies for sleep disorders. Use phototherapy, transcranial electrical/magnetic stimulation and other therapies to conduct self-controlled intervention studies on insomnia, narcolepsy, and rapid eye movement sleep behavior disorder .Read full original descriptionShow less

Carry out precise and effective neuromodulation interventions, and develop new neuromodulation technologies for sleep disorders. Use phototherapy, transcranial electrical/magnetic stimulation and other therapies to conduct self-controlled intervention studies on insomnia, narcolepsy, and rapid eye movement sleep behavior disorder .

Inclusion: Patients with insomnia, narcolepsy,and RBD that have been clearly diagnosed by specialists should sign the informed consent form.

Exclusion: Patients with major neurological diseases such as multi-infarct dementia, Huntington\'s disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded; A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria); History of severe drug or alcohol abuse within the past year; Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer; Have significant hearing, visual, or cognitive impairments, or are unable to participate in interviews in a meaningful way.

ClinicalTrials.gov NCT06797284